Cite
APA Citation
van Veelen, A., Abtahi, S., Souverein, P., Driessen, J. H., Klungel, O. H., Dingemans, A. C., van Geel, R., de Vries, F., & Croes, S. (2022). characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer epidemiology, 78, . http://access.bl.uk/ark:/81055/vdc_100155154348.0x000010